A new, small robotic camera designed to be swallowed for use in medical examinations was recently demonstrated at a conference in Canada. The device called PillBot can be guided through a body remotely, meaning electronically from outside. Its creators hope the device will replace traditional endoscopies. An endoscopy is when a camera attached to a wire is directed down the throat and into a sleeping patient's stomach.
最近在加拿大的一次会议上展示了一种新型的小型机器人相机，该相机被设计为可吞咽的，用于医学检查。这种名为PillBot的设备可以远程引导人体，也就是从外部进行电子引导。发明者希望该设备能取代传统的内窥镜检查。内窥镜检查是指将一架连接在电线上的摄像机沿着喉咙进入睡眠患者的胃。
The company Endiatx based in Hayward, California, developed the device. The research hospital, Mayo Clinic, in Rochester, Minnesota, is a partner in the project.
位于加州海沃德的Endiatx公司开发了这种设备。位于明尼苏达州罗彻斯特的研究型医院梅奥诊所是该项目的合作伙伴。
The PillBot is designed to be the first motorized endoscopic camera. Here is how developers say it works: A patient does not eat for one day, then swallows the PillBot with lots of water. The PillBot acts like a small submarine controlled by a wireless remote control. When the exam is complete, the body will expel the PillBot in the same way it expels other solid waste.
PillBot被设计为第一个电动内窥镜相机。开发人员是这样说它的工作原理的:病人一天不吃东西，然后用大量的水吞下PillBot。PillBot就像一艘由无线遥控器控制的小型潜艇。当检查完成后，身体会像排出其他固体废物一样排出PillBot。
Dr. Vivek Kumbhari is co-founder of the company. He is professor of medicine and chairman of gastroenterology and hepatology at the Mayo Clinic. It is the latest step toward his larger goal of making complex medicine more accessible.
Vivek Kumbhari博士是该公司的联合创始人。他是梅奥诊所的医学教授兼胃肠病学和肝病学主席。这是他使复杂药物更容易获得的更大目标的最新一步。
If endoscopies can be moved from a hospital setting to a patient's home, he said, "then I think we have achieved that goal." Use of the device would require fewer medical workers and no anesthesia, he said. The device provides "a safer, more comfortable approach," he added.
他说，如果内窥镜检查可以从医院搬到病人家里，“那么我认为我们已经实现了这个目标。”他说，使用这种设备将需要更少的医务人员，也不需要麻醉。他补充说，该设备提供了“一种更安全、更舒适的方法”。
Kumbhari also said the technology is more efficient and permits people to get treatment earlier in the progress of a disease.
Kumbhari还说，这项技术更有效，可以让人们在疾病进展的早期得到治疗。
Alex Luebke is the co-founder of Endiatx. He said the PillBot can help people in rural areas where medical centers and treatment are lacking.
Alex Luebke是Endiatx的联合创始人。他说，PillBot可以帮助缺乏医疗中心和治疗的农村地区的人们。
"Especially in developing countries, there is no access" to complex medical care, he said. "So being able to have the technology, gather all that information and provide you the solution, even in remote areas - that's the way to do it."
他说，“特别是在发展中国家，人们无法获得”复杂的医疗服务。“因此，能够拥有技术，收集所有信息并为您提供解决方案，即使是在偏远地区-这就是做到这一点的方法。”
The micro-robotic pill is undergoing testing. It could come before the U.S. Food and Drug Administration for consideration in the coming months. If approved, the PillBot could be available by 2026.
这种微型机器人药丸正在进行测试。它可能会在未来几个月提交美国食品和药物管理局(fda)审议。如果获得批准，PillBot将于2026年上市。
Kumbhari hopes the technology can be expanded to the bowels, vascular system, heart, liver, brain and other parts of the body.
Kumbhari希望这项技术可以扩展到肠道、血管系统、心脏、肝脏、大脑和身体的其他部位。
最近在加拿大的一次会议上展示了一种新型的小型机器人相机，该相机被设计为可吞咽的，用于医学检查。这种名为PillBot的设备可以远程引导人体，也就是从外部进行电子引导。发明者希望该设备能取代传统的内窥镜检查。内窥镜检查是指将一架连接在电线上的摄像机沿着喉咙进入睡眠患者的胃。
The company Endiatx based in Hayward, California, developed the device. The research hospital, Mayo Clinic, in Rochester, Minnesota, is a partner in the project.
位于加州海沃德的Endiatx公司开发了这种设备。位于明尼苏达州罗彻斯特的研究型医院梅奥诊所是该项目的合作伙伴。
The PillBot is designed to be the first motorized endoscopic camera. Here is how developers say it works: A patient does not eat for one day, then swallows the PillBot with lots of water. The PillBot acts like a small submarine controlled by a wireless remote control. When the exam is complete, the body will expel the PillBot in the same way it expels other solid waste.
PillBot被设计为第一个电动内窥镜相机。开发人员是这样说它的工作原理的:病人一天不吃东西，然后用大量的水吞下PillBot。PillBot就像一艘由无线遥控器控制的小型潜艇。当检查完成后，身体会像排出其他固体废物一样排出PillBot。
Dr. Vivek Kumbhari is co-founder of the company. He is professor of medicine and chairman of gastroenterology and hepatology at the Mayo Clinic. It is the latest step toward his larger goal of making complex medicine more accessible.
Vivek Kumbhari博士是该公司的联合创始人。他是梅奥诊所的医学教授兼胃肠病学和肝病学主席。这是他使复杂药物更容易获得的更大目标的最新一步。
If endoscopies can be moved from a hospital setting to a patient's home, he said, "then I think we have achieved that goal." Use of the device would require fewer medical workers and no anesthesia, he said. The device provides "a safer, more comfortable approach," he added.
他说，如果内窥镜检查可以从医院搬到病人家里，“那么我认为我们已经实现了这个目标。”他说，使用这种设备将需要更少的医务人员，也不需要麻醉。他补充说，该设备提供了“一种更安全、更舒适的方法”。
Kumbhari also said the technology is more efficient and permits people to get treatment earlier in the progress of a disease.
Kumbhari还说，这项技术更有效，可以让人们在疾病进展的早期得到治疗。
Alex Luebke is the co-founder of Endiatx. He said the PillBot can help people in rural areas where medical centers and treatment are lacking.
Alex Luebke是Endiatx的联合创始人。他说，PillBot可以帮助缺乏医疗中心和治疗的农村地区的人们。
"Especially in developing countries, there is no access" to complex medical care, he said. "So being able to have the technology, gather all that information and provide you the solution, even in remote areas - that's the way to do it."
他说，“特别是在发展中国家，人们无法获得”复杂的医疗服务。“因此，能够拥有技术，收集所有信息并为您提供解决方案，即使是在偏远地区-这就是做到这一点的方法。”
The micro-robotic pill is undergoing testing. It could come before the U.S. Food and Drug Administration for consideration in the coming months. If approved, the PillBot could be available by 2026.
这种微型机器人药丸正在进行测试。它可能会在未来几个月提交美国食品和药物管理局(fda)审议。如果获得批准，PillBot将于2026年上市。
Kumbhari hopes the technology can be expanded to the bowels, vascular system, heart, liver, brain and other parts of the body.
Kumbhari希望这项技术可以扩展到肠道、血管系统、心脏、肝脏、大脑和身体的其他部位。
